Page 1242 · Percutaneous driveline exit-site risk, care protocol, and infection escalation pathway for durable LVAD support
A left ventricular assist device (LVAD) sustains circulation with an implanted pump, but that pump must stay connected to an external controller and battery pack. The driveline — a cable bundle carrying power and control signals — exits the abdominal wall through a surgically created tunnel and a skin exit site. Unlike a healed surgical incision, this exit site remains a permanent, unhealed interface between the sterile inside of the body and the non-sterile outside world for as long as the device is in place.
A standard surgical incision closes, re-epithelializes, and eventually becomes a resilient scar with an intact skin barrier. The driveline exit site cannot do this because a foreign object — the driveline itself — permanently occupies the tract.
Instead of closing, the body forms a chronic epithelialized sinus tract that lines the path from skin surface down to the subcutaneous tunnel. This tract is more fragile than normal skin, has less robust local blood supply, and is constantly exposed to mechanical stress from the driveline moving with body motion, clothing friction, and daily activity.
Because the tract never fully matures into resilient scar tissue, it remains vulnerable to colonization by skin flora and environmental organisms for as long as the device remains implanted — which may be years, or permanently for patients on destination therapy.
The driveline path has several anatomic zones, each with different infection implications:
• Skin exit site — the visible opening where the driveline emerges; the most accessible site for daily inspection and dressing care • Subcutaneous tunnel — the tract beneath the skin connecting the exit site to the pump; infection here is harder to see and monitor directly • Pump pocket — the deep space around the implanted pump itself; the most serious site for infection to reach, given its proximity to the device and great vessels
Infection typically starts superficially at the exit site and, if uncontrolled, can track along the driveline tunnel toward the pump pocket — a process sometimes described as an infection "climbing the line." This is why superficial-appearing redness or drainage is never treated as purely cosmetic.
Because the driveline exit site can never fully seal, driveline infection is considered one of the most common and consequential complications of long-term mechanical circulatory support — prevention through daily site care is far more effective than treatment after infection develops.
Because the driveline exit site cannot heal in the traditional sense, disciplined, consistent dressing care is the single most effective infection-prevention measure available to patients and caregivers. A standardized, sterile technique performed on a fixed schedule keeps bacterial colonization low and allows early detection of any change in the site's appearance.
A consistent, step-by-step technique reduces contamination risk and creates a routine that makes any deviation from "normal" easier to notice:
1. Hand hygiene — thorough handwashing before assembling supplies, mask on if recommended by center protocol 2. Careful removal of the old dressing, watching for signs of drainage, odor, or adherent crusting 3. Visual inspection of the exit site — color, swelling, drainage, and driveline position all documented or noted 4. Cleansing with an antiseptic solution (e.g., chlorhexidine, per protocol) using a single-pass, outward-spiral wiping technique to avoid dragging organisms back across the site 5. Allowing the antiseptic to fully air-dry before covering — trapping moisture undermines the barrier 6. Application of a fresh sterile dressing, applied to lie flat with no tension pulling on the driveline 7. Re-securing the driveline anchor device to eliminate slack and prevent tugging
This routine is typically performed 2–3 times weekly, or immediately if the dressing becomes wet, loose, soiled, or visibly lifted.
No individual step in the dressing-change protocol is complicated in isolation, but the protective effect comes from consistent, correct repetition over months and years. A single missed or rushed dressing change rarely causes infection by itself — the risk accumulates from repeated lapses, unclean technique, or long gaps between changes.
Patients and caregivers are trained extensively before hospital discharge and are encouraged to treat the routine with the same seriousness as medication dosing: same schedule, same steps, same supplies, every time. Written checklists and teach-back demonstrations are standard parts of LVAD patient education programs.
Care consistency is the single strongest modifiable factor in driveline infection risk. Patients who reliably follow the dressing protocol experience substantially fewer exit-site infections than those with irregular or improvised technique.
Beyond cleanliness, the physical stability of the driveline at the exit site matters enormously. Every tug, pull, or repetitive back-and-forth motion of the driveline within its tract causes microscopic trauma to the surrounding tissue — trauma that provides bacteria an easier foothold and slows down the tissue's ability to maintain any protective barrier.
The driveline exit site is, in effect, a small wound that is permanently held open by the driveline itself. Anything that increases motion of the driveline within the tract — tugging while dressing, snagging on furniture or clothing, or simply an unanchored line swinging with body movement — repeatedly stresses the fragile epithelial tract lining.
This repetitive micromotion: • Disrupts the delicate epithelial lining that forms the body's only barrier at the tract • Creates microscopic breaks that serve as new entry points for bacteria • Triggers a low-grade local inflammatory response that can mask or mimic early infection signs • Widens the tract opening over time, increasing drainage and irritation
For this reason, LVAD teams emphasize that anchoring the driveline is not a convenience feature — it is a core infection-prevention measure, equal in importance to the dressing protocol itself.
Driveline immobilization typically combines several layers of protection:
• An abdominal binder or dedicated anchor pad that holds the external driveline against the body, removing slack near the exit site • A securement device or adhesive anchor a short distance from the exit site itself, so that any pulling force is absorbed away from the fragile tract rather than directly at the skin • Clothing choices that avoid tight waistbands or fabric that can snag the line • Consistent line management during transfers, showering (with appropriate device protection), and physical activity
Patients are coached to perform a quick daily check: confirm the anchor is snug, the line has no unsupported loops, and there is no tension pulling directly on the exit site. This habit, paired with sterile dressing changes, forms the two-pillar foundation of driveline infection prevention.
Minimizing micromotion at the exit site is as important as sterile technique — a perfectly clean dressing change cannot fully protect tissue that is being repeatedly traumatized by an unanchored, mobile driveline.
Despite best preventive efforts, driveline infections still occur. The difference between a quickly treated superficial infection and a serious deep infection often comes down to how early the warning signs are recognized and reported. Patients and caregivers are trained to check the exit site daily and to treat any change from baseline as worth reporting promptly.
A driveline exit site infection can present with any combination of the following signs, ranging from subtle to obvious:
• Redness (erythema) extending beyond the immediate exit site, especially if spreading or new • Drainage that is cloudy, yellow, green, or foul-smelling — clear, minimal drainage can be normal, but any change in color, volume, or odor is notable • Localized pain or tenderness at or around the exit site, particularly if new or worsening • Warmth to the touch around the site • Swelling or firmness in the surrounding tissue • Fever or general malaise, which may indicate the infection has become more than purely local
Because the exit site is inspected at every dressing change, patients become familiar with their own "normal" appearance, which makes any deviation easier to notice quickly.
A superficial driveline infection caught early is generally far easier to manage — often with local wound care, more frequent dressing changes, and sometimes a course of oral antibiotics — than an infection that has been allowed to progress.
Delayed recognition allows the infection time to spread along the subcutaneous tunnel toward the pump pocket, at which point treatment becomes substantially more complex, potentially requiring intravenous antibiotics, imaging to assess the extent of spread, or surgical intervention.
LVAD programs therefore emphasize a simple rule to patients: any new redness, drainage, or pain at the exit site is reported the same day it is noticed — it is never something to "wait and see" about.
The clinical teaching is direct and consistent across LVAD programs: any redness, drainage, or pain at the driveline exit site should prompt same-day contact with the VAD team, since prompt evaluation is what prevents a superficial infection from tracking deeper.
If a driveline infection is not identified and treated early, it can progress beyond the skin exit site, tracking along the subcutaneous tunnel toward the deep tissue surrounding the implanted pump. Deep driveline or pump pocket infection represents one of the most serious complications of long-term LVAD support, with implications that extend well beyond a course of antibiotics.
When bacteria are not cleared at the exit site — due to delayed treatment, an especially virulent organism, or ongoing mechanical trauma reintroducing bacteria — infection can extend along the epithelialized tunnel that surrounds the driveline. This tract effectively becomes a conduit that infection can travel through, deeper into the body, toward the space surrounding the implanted pump itself.
Once infection reaches the pump pocket, it is now adjacent to the device hardware and, in some cases, can form a biofilm on the pump surface itself — a layer of bacteria embedded in a protective matrix that is markedly more resistant to antibiotics than free-floating bacteria. This is what makes deep, device-related infection so much harder to eradicate than a superficial skin infection.
Deep driveline or pump pocket infection typically requires a substantially more intensive treatment course than superficial infection:
• Prolonged intravenous antibiotic therapy — often weeks to months, sometimes extending for as long as the device remains implanted (chronic suppressive therapy) • Advanced imaging (CT, ultrasound, or nuclear medicine studies) to define the extent of infection along the tunnel and around the pump • Surgical debridement of infected tissue, driveline exit-site revision (relocating the exit site), or in severe cases, pocket washout procedures • Close coordination with infectious disease specialists to select and monitor antibiotic therapy
Beyond the physical treatment burden, a persistent device-related infection can complicate a patient's candidacy for heart transplantation — active, uncontrolled infection is generally a contraindication to transplant listing, since immunosuppression after transplant would allow the infection to flourish. This is one of the reasons LVAD programs treat driveline infection prevention with such rigor from the very first day of discharge.
The entire structure of driveline care — sterile dressing changes, diligent immobilization, and same-day reporting of warning signs — exists to prevent this final stage. Deep pump pocket infection is difficult, costly, and sometimes life-altering to treat, which is why prevention and early recognition remain the two most powerful tools available to patients and their care teams.